Yun-Song Li and Xiang-Ling Meng
Objective: To investigate the risk factors and drug-resistance of Escherichia coli in patients with Biliary Tract Infections (BTIs). In addition, prognostic factors related to survival in patients with BTI were evaluated. Methods: A retrospective observational study was performed to analyze the relationship between antimicrobial use and bacterial resistance. Results: Biliary tract infection caused by E. coli was diagnosed in 0.81% of patients from general surgery (107 of 13163) admitted to the hospital between January 1, 2012 and December 31, 2014. Of the 107 isolates, 102 (95.3%) were resistant to at least one antimicrobial agent and 86.9% (93/107) to two or more antibiotics. 80.4% were resistant to piperacillin, 27.1% to piperacillin/tazobactam, 61.7% to cefuroxime, 57% to cefoxitin, 48.6% to cefotaxime, 43.9% to ceftazidime, 38.3% to cefepime, 44.8% to levofloxacin. However, all strains were susceptible to imipenem. The detection rates of ESBLs-producing Escherichia coli were 41.1%. Conclusion: Prior receipt of antimicrobial therapy was significantly associated with infection caused by resistant organism and most strains were resistant to multiple antimicrobial agents.
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu